Company Name or Ticker Symbol
Search for other Categories

Regenerx Biopharmaceuticals Inc  (RGRX)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs

Regenerx Biopharmaceuticals Inc's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

Return On Assets (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Total Assets Change 375.93 % 140.73 % 68.97 % 159.19 % -89.95 %
Y / Y Net Income Change - - - - -
Return On Assets (TTM) 349.48 % 23.95 % - - -
Total Ranking # 20 # 0 # 0 # 0 #
Seq. Total Assets Change -37.24 % -28.24 % -27.13 % 1350.02 % -68.25 %
Seq. Net Income Change - - - - -

Roa Comment
Regenerx Biopharmaceuticals Inc yielded Return on Asset in I. Quarter above company average, at 349.48 %.

Despite detoriation in net income, company improved ROA compare to previous quarter.

Within Healthcare sector 2 other companies have achieved higher return on assets. While total ranking remained unchanged compare to previous quarter at no. .

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 1
Sector # 3
Overall # 20

Return On Assets Statistics
High Average Low
349.48 %
186.71 %
23.95 %
(Mar 31 2017)   (Dec 31 2016)

You need to upgrade your Flash Player
Financial Statements
Regenerx Biopharmaceuticals Inc's Equity $ -6 Millions RGRX's Balance sheet
Regenerx Biopharmaceuticals Inc's Income $ 0 Millions Quarterly RGRX's Income Statement
RGRX's Income by Division See RGRX's Income by Division

More Return On Equity Ratios
Biotechnology & Drugs Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
RGRX's Roa Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for RGRX's Competitors
Roa for Regenerx Biopharmaceuticals Inc's Suppliers
Return On Asstes for RGRX's Customers

You may also want to know
RGRX's Roi RGRX's Inventory Turnover Ratio RGRX's Growth Rates RGRX's Dividend Comparisons
RGRX's Annual Roi RGRX's Profitability Ratios RGRX's Asset Turnover Ratio RGRX's Dividend Growth
RGRX's Roe RGRX's Valuation Ratios RGRX's Financial Strength Ratios RGRX's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2017, within Healthcare Sector ROA
Regenerx Biopharmaceuticals Inc  349.48 %
Pharmathene, Inc  219.02 %
Prophase Labs, Inc.  182.12 %
Ophthalix, Inc.  169.96 %
Steadymed Ltd.  145.38 %
International Stem Cell Corp  137.42 %
Capstone Therapeutics Corp.  133.50 %
Greenestone Healthcare Corp  127.56 %
Mannkind Corp  125.49 %
Nascent Biotech Inc.  113.05 %
Tenax Therapeutics, Inc.  100.61 %
Neurometrix, Inc.  77.36 %
Elite Pharmaceuticals Inc  70.86 %


Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
LVPR's Profile
Stock Price
LVPR's Financials
LVPR's Expectations
Business Description
Charts & Quotes
LVPR's News
LVPR's Competitors
Customers & Markets
Economic Indicators
LVPR's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com